Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.
Curr Opin Organ Transplant. 2010 Oct;15(5):608-13. doi: 10.1097/MOT.0b013e32833da439.
With improving survival rates following solid organ transplantation, assessment of its success has broadened with a focus on long-term outcomes, including nongraft-related medical outcomes and family and patient perceptions of quality of life. Posttransplant renal dysfunction contributes to long-term morbidity and mortality following pediatric liver transplantation. In this review, we provide an overview of our understanding and approach to managing posttransplant renal dysfunction and highlight the existing gaps in knowledge in this area.
The literature regarding renal dysfunction following liver transplant primarily focuses on the experience in the adult population. Studies on children are limited by small numbers and varying definitions of outcomes. Thus, lessons in the current literature must be closely examined before they can be extrapolated and applied to children.
The current literature validates that posttransplant renal dysfunction is a frequent and important outcome for adults and children. Although the characteristics of children at high risk are less clear, calcineurin inhibitor minimization is considered a viable strategy for preserving renal function. The risk-benefit ratio of kidney biopsy in children and the possibility of renal preservation via immunosuppression withdrawal are intriguing concepts that remain to be defined.
随着实体器官移植后存活率的提高,对其成功的评估范围已经扩大,包括非移植相关的医疗结果以及家庭和患者对生活质量的感知。移植后肾功能障碍是小儿肝移植后长期发病率和死亡率的重要因素。在这篇综述中,我们概述了我们对移植后肾功能障碍的理解和处理方法,并强调了该领域现有知识空白。
关于肝移植后肾功能障碍的文献主要集中在成人人群的经验上。关于儿童的研究受到数量有限和结果定义不同的限制。因此,在将目前文献中的经验推广和应用于儿童之前,必须仔细检查。
目前的文献证实,移植后肾功能障碍是成人和儿童的常见且重要的结果。虽然高风险儿童的特征尚不清楚,但钙调神经磷酸酶抑制剂最小化被认为是保护肾功能的一种可行策略。儿童肾活检的风险效益比以及通过免疫抑制药物撤药实现肾脏保护的可能性是尚未明确的有趣概念。